Press release
United States Human Papillomavirus (HPV) Vaccines Market to Reach USD 12.36 Billion by 2033, Led by Merck, GSK, and Walvax Biotechnology | DataM Intelligence
The global Human Papillomavirus (HPV) Vaccines Market reached USD 3,043.19 Million in 2024 and is projected to reach USD 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033, according to DataM Intelligence.United States: Recent Industry Developments
✅ In October 2025, The CDC expanded HPV vaccination recommendations to include adults up to age 45, significantly increasing the eligible population.
✅ In October 2025, Merck received FDA approval for its next-generation HPV vaccine offering broader protection against additional high-risk strains.
✅ In October 2025, A national public health campaign was launched to increase HPV vaccination rates among adolescents and young adults.
Japan: Recent Industry Developments
✅ In October 2025, Japan's Ministry of Health reinstated active recommendation for HPV vaccination after a decade-long suspension.
✅ In October 2025, Takeda Pharmaceutical partnered with international vaccine manufacturers to enhance HPV vaccine distribution across Japan.
✅ In October 2025, A government-funded catch-up vaccination program was initiated for women who missed HPV vaccination during the suspension period.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/human-papillomavirus-vaccines-market?jd
Market Trends & Drivers
The Human Papillomavirus (HPV) Vaccines Market is experiencing robust growth driven by expanding immunization programs, increasing awareness about cervical cancer prevention, and government initiatives for vaccination coverage. Key trends include the development of next-generation vaccines with broader protection, expansion of vaccination to male populations, and implementation of school-based vaccination programs. The growing focus on cancer prevention, coupled with improving healthcare infrastructure in emerging economies and rising disposable income, is significantly accelerating market expansion.
Competitive Landscape
The market is dominated by a few key players with strong research capabilities and global distribution networks.
Merck & Co., Inc. leads the market with Gardasil and Gardasil 9, maintaining the largest market share globally.
GlaxoSmithKline plc (GSK) markets Cervarix, focusing on specific markets and population segments.
Walvax Biotechnology Co., Ltd. has emerged as a significant player with its locally developed HPV vaccine in China.
Serum Institute of India Pvt. Ltd. is developing affordable HPV vaccines to increase accessibility in low-income countries.
Innovax Pharmaceuticals is advancing its HPV vaccine candidates through clinical development stages.
Johnson & Johnson is investing in HPV vaccine research through its pharmaceutical division.
AstraZeneca PLC is exploring novel vaccine technologies for HPV prevention.
Pfizer Inc. is investigating HPV vaccine opportunities through its vaccine research division.
Sanofi Pasteur is developing next-generation HPV vaccine candidates.
Bharat Biotech is working on indigenous HPV vaccine development for emerging markets.
Segmentation
By Type (Bivalent, Quadrivalent, Nonavalent)
By Gender (Female, Male)
By Age Group (Children, Adults, Geriatrics)
By End-Users (Hospitals, Clinics, Others)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/human-papillomavirus-vaccines-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialize in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Human Papillomavirus (HPV) Vaccines Market to Reach USD 12.36 Billion by 2033, Led by Merck, GSK, and Walvax Biotechnology | DataM Intelligence here
News-ID: 4222938 • Views: …
More Releases from DataM intelligence 4 Market Research LLP

United States Sickle Cell Anaemia Testing Market 2025 | Growth Drivers, Competit …
Market Size and Growth
Sickle Cell Anaemia Testing Market is expected to reach at a high CAGR during the forecast period (2024-2031).
Key Development:
United States: Recent Industry Developments
✅ In October 2025, Terumo Blood and Cell Technologies and Hemex Health announced the expansion of their Gazelle® diagnostic platform, now available in over 40 countries. This portable, low-cost device enables rapid identification of hemoglobin variants, aiding in the diagnosis of sickle cell and beta…

United States Oral Contraceptive Pills Market to Reach USD 38.16 Billion by 2033 …
The global Oral Contraceptive Pills Market reached USD 19.85 Billion in 2024 and is projected to reach USD 38.16 Billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Bayer AG received FDA approval for its next-generation oral contraceptive with reduced side effects and improved cycle control.
✅ In October 2025, The American…

United States Health Insurance Market Projected to Expand at 5.2% CAGR, Reaching …
The global Health Insurance Market reached USD 621.35 billion in 2023 and is projected to reach USD 2408.49 billion by 2031, growing at a CAGR of 5.2% during the forecast period 2024-2031, according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, UnitedHealth Group launched a new AI-powered platform for personalized premium calculations and real-time claims processing.
✅ In October 2025, The Centers for Medicare & Medicaid…

Peptide Therapeutics Market Growth Outlook 2024-2031: Innovations, Key Players, …
Recent market intelligence suggests that the Peptide Therapeutics Market is expected to grow at a compound annual growth rate (CAGR) of around 7.8% between 2024 and 2031. The market is segmented by type (patented vs generic), route of administration (oral, parenteral), synthesis technology (solid-phase, liquid, hybrid), and application area (cancer, metabolic, cardiovascular, CNS, infectious diseases). The North America region currently commands the largest share owing to robust biopharma R&D investment,…
More Releases for HPV
Human Papillomavirus (HPV) Vaccine: Core Growth Enabler in the Rising Prevalence …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Human Papillomavirus (HPV) Vaccine Industry Market Size Be by 2025?
The market size for the Human Papillomavirus (HPV) vaccine has seen a swift expansion in the past few years. The market is projected to inflate from $5.8 billion in 2024 to $6.57 billion in 2025, marking…
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033.
The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data…
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period?
The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The…
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026.
Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962
Top Key Players: GSK, Merck.
An Overview of the Impact of COVID-19 on HPV Vaccines Market:
The emergence of COVID-19 has brought…
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385
In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share…
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing.
The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,…